|
Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, Mayor-Torroglosa S, Miralles de Imperial J, Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 2002;109(1):157-68. PubMed PMID: 11784707.
AÑO: 2002; IF: 3.457
|
11784707
|
Sellés-Navarro I, Villegas-Pérez MP, Salvador-Silva M, Ruiz-Gómez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996 Sep;37(10):2002-14. PubMed PMID: 8814140.
AÑO: 1996; IF: 4.091
|
|
Nadal-Nicolás FM, Rodriguez-Villagra E, Bravo-Osuna I, Sobrado-Calvo P, Molina-Martínez I, Villegas-Pérez MP, Vidal-Sanz M, Agudo-Barriuso M, Herrero-Vanrell R. Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1183-92. doi: 10.1167/iovs.15-18213. PubMed PMID: 26975030.
AÑO: 2016; IF: 3.303
|
|
Madeira MH, Ortin-Martinez A, Nadal-Nícolas F, Ambrósio AF, Vidal-Sanz M, Agudo-Barriuso M, Santiago AR. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Sci Rep. 2016 Jun 8;6:27532. doi: 10.1038/srep27532. PubMed PMID: 27270337; PubMed Central PMCID: PMC4897621.
AÑO: 2016; IF: 4.259
|
|
Wang J, Valiente-Soriano FJ, Nadal-Nicolás FM, Rovere G, Chen S, Huang W, Agudo-Barriuso M, Jonas JB, Vidal-Sanz M, Zhang X. MicroRNA regulation in an animal model of acute ocular hypertension. Acta Ophthalmol. 2017 Feb;95(1):e10-e21. doi: 10.1111/aos.13227. Epub 2016 Aug 18. PubMed PMID: 27535721; PubMed Central PMCID: PMC6213559.
AÑO: 2017; IF: 3.324
|